News
Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...
Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Abbott Laboratories (NYSE:ABT) Q4 2023 Earnings Conference Call January 24, 2024 9:00 AM ETCompany Participants. Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief ...
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...
The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...
Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.19 EPS, expectations were $1.19. ... Welcome to Abbott’s Fourth Quarter 2023 Earnings Conference Call.
Abbott Laboratories (NYSE:ABT) Q2 2024 Earnings Conference Call July 18, 2024 9:00 AM ETCompany Participants. Robert Ford - Chief Executive Officer Phil Boudreau - Executive Vice President ...
Abbott Laboratories beats earnings expectations. Reported EPS is $1.14, expectations were $1.1. Operator: Good morning, and thank you for standing by. Welcome to Abbott’s Third Quarter 2023 ...
Abbott Laboratories (NYSE: ABT) Q4 2023 Earnings Call Jan 24, 2024, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepared ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results